PrecisCa
Sherry Crowe is an accomplished professional in the oncology field with extensive experience in business development and marketing. Currently serving as Executive VP-Business Development at PrecisCa, Sherry has significantly contributed to enhancing cancer care through innovative consultancy roles, including Chief Executive Officer at OncoConnect LLC. Sherry has held pivotal positions on various Business Advisory Boards and has previously led business development at Ontada, a McKesson division, focusing on real-world evidence and provider education for biotechnology firms. Sherry's career includes notable achievements at Novartis Oncology, where Sherry excelled in commercial launch initiatives and market access for multiple oncology agents. With a foundation in oncology sales management at Roche Oncology and early career experience at Bristol Myers Squibb, Sherry is a proven leader in the oncology marketplace. Educational qualifications include degrees from the Lazaridis School of Business & Economics and Northwestern University's Kellogg School of Management.
This person is not in any teams
This person is not in any offices
PrecisCa
PrecisCa gives oncology providers and their patients access to top expert insights through multidisciplinary virtual expert cancer panels and educational videos aka "Lecturettes". Our independent, licensable video library featuring KOLs has a number of uses and the data collected through our platform can provide valuable insights such as practice patterns PrecisCa’s virtual tumor boards or "Expert Cancer Panels" brings the benefits of a SECOND OPINION to the average patient facing cancer, at a much more affordable price point, at the point of care, in their communities, avoiding the cost and inconvenience of traveling, staying away from home and work. Expediting care may lead to lower overall insurances costs and increased patient satisfaction.